JP2008509677A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509677A5
JP2008509677A5 JP2007525861A JP2007525861A JP2008509677A5 JP 2008509677 A5 JP2008509677 A5 JP 2008509677A5 JP 2007525861 A JP2007525861 A JP 2007525861A JP 2007525861 A JP2007525861 A JP 2007525861A JP 2008509677 A5 JP2008509677 A5 JP 2008509677A5
Authority
JP
Japan
Prior art keywords
tumors
usa
days
cells
tetramer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007525861A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509677A (ja
JP5530065B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/028895 external-priority patent/WO2006017856A2/en
Publication of JP2008509677A publication Critical patent/JP2008509677A/ja
Publication of JP2008509677A5 publication Critical patent/JP2008509677A5/ja
Application granted granted Critical
Publication of JP5530065B2 publication Critical patent/JP5530065B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007525861A 2004-08-13 2005-08-15 抗生物質耐性欠失ワクチンの作成方法 Expired - Fee Related JP5530065B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60149204P 2004-08-13 2004-08-13
US60/601,492 2004-08-13
PCT/US2005/028895 WO2006017856A2 (en) 2004-08-13 2005-08-15 Methods for constructing antibiotic resistance free vaccines

Publications (3)

Publication Number Publication Date
JP2008509677A JP2008509677A (ja) 2008-04-03
JP2008509677A5 true JP2008509677A5 (https=) 2008-06-26
JP5530065B2 JP5530065B2 (ja) 2014-06-25

Family

ID=35839990

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007525861A Expired - Fee Related JP5530065B2 (ja) 2004-08-13 2005-08-15 抗生物質耐性欠失ワクチンの作成方法

Country Status (9)

Country Link
US (4) US8906664B2 (https=)
EP (2) EP2942391B1 (https=)
JP (1) JP5530065B2 (https=)
AU (1) AU2005271246A1 (https=)
CA (1) CA2577306A1 (https=)
DK (2) DK2942391T3 (https=)
ES (2) ES2543079T3 (https=)
PT (2) PT2942391T (https=)
WO (1) WO2006017856A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7794729B2 (en) * 1994-11-08 2010-09-14 The Trustees Of The University Of Pennsylvania Methods and compositions for immunotherapy of cancer
US8791237B2 (en) 1994-11-08 2014-07-29 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of non-hodgkins lymphoma
US8956621B2 (en) 1994-11-08 2015-02-17 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of cervical dysplasia
US8114414B2 (en) * 1994-11-08 2012-02-14 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of cervical cancer
US7820180B2 (en) * 2004-09-24 2010-10-26 The Trustees Of The University Of Pennsylvania Listeria-based and LLO-based vaccines
US9012141B2 (en) 2000-03-27 2015-04-21 Advaxis, Inc. Compositions and methods comprising KLK3 of FOLH1 antigen
AU2001255196A1 (en) * 2000-03-29 2001-10-08 The Trustees Of The University Of Pennsylvania Compositions and methods for enhancing immunogenicity of antigens
US8771702B2 (en) * 2001-03-26 2014-07-08 The Trustees Of The University Of Pennsylvania Non-hemolytic LLO fusion proteins and methods of utilizing same
US7700344B2 (en) * 2001-03-26 2010-04-20 The Trustees Of The University Of Pennsylvania Compositions and methods for enhancing the immunogenicity of antigens
US7794728B2 (en) * 2002-05-29 2010-09-14 The Regents Of The University Of California Attenuated Listeria spp. and methods for using the same
PT2942391T (pt) 2004-08-13 2018-10-09 Univ Pennsylvania Métodos de produção de vacinas não resistentes aos antibióticos
EP2860253B1 (en) * 2006-03-01 2018-08-01 Aduro Biotech, Inc. Engineered listeria and methods of use thereof
WO2008066774A2 (en) 2006-11-22 2008-06-05 The Regents Of The University Of California INTERFERON-β PRODUCTION MODULATING LISTERIA STRAINS AND METHODS FOR USING SAME
WO2008130551A2 (en) * 2007-04-16 2008-10-30 The Trustees Of The University Of Pennsylvania Antibiotic resistance free listeria strains and methods for constructing and using same
JP2010534058A (ja) * 2007-04-16 2010-11-04 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 抗生物質耐性のないリステリア菌およびその構築および使用方法
US20110129499A1 (en) * 2008-05-19 2011-06-02 Paulo Maciag Dual delivery system for heterologous antigens
US9017660B2 (en) 2009-11-11 2015-04-28 Advaxis, Inc. Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
US9650639B2 (en) 2008-05-19 2017-05-16 Advaxis, Inc. Dual delivery system for heterologous antigens
WO2010102140A1 (en) 2009-03-04 2010-09-10 The Trustees Of The University Of Pennsylvania Compositions comprising angiogenic factors and methods of use thereof
US10016617B2 (en) 2009-11-11 2018-07-10 The Trustees Of The University Of Pennsylvania Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
JP5985397B2 (ja) * 2009-11-11 2016-09-06 アドバクシス インコーポレイテッド 組換えリステリア株およびそれを含む免疫原性組成物
WO2012138377A2 (en) * 2010-10-01 2012-10-11 Trustees Of The University Of Pennsylvania The use of listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals
CA2829960A1 (en) * 2011-03-11 2012-09-20 John Rothman Listeria-based adjuvants
WO2013138337A1 (en) 2012-03-12 2013-09-19 Advaxis Suppressor cell function inhibition following listeria vaccine treatment
JP2017511796A (ja) 2014-02-18 2017-04-27 アドバクシス， インコーポレイテッド 多標的免疫療法を目的とするバイオマーカー
AU2015227163A1 (en) * 2014-03-05 2016-10-20 Advaxis, Inc. Methods and compositions for increasing a T-effector cell to regulatory T cell ratio
EP3134510B1 (en) * 2014-04-24 2023-11-01 Advaxis, Inc. Recombinant listeria vaccine strains and methods of producing the same
CN107429289A (zh) * 2014-10-14 2017-12-01 宾夕法尼亚大学理事会 用于癌症治疗的联合疗法
MA41644A (fr) 2015-03-03 2018-01-09 Advaxis Inc Compositions à base de listeria comprenant un système d'expression de minigènes codant pour des peptides, et leurs procédés d'utilisation
KR20180021874A (ko) * 2015-06-26 2018-03-05 바이엘 애니멀 헬스 게엠베하 시토졸 dna 감시 분자의 조절 방법
EP3344751A4 (en) 2015-09-02 2019-03-27 The Regents of the University of California METHOD AND COMPOSITIONS FOR MODULATING THE ACTIVATION OF A PRFA-MEDIATED VIRULENT GENE IN LISTERIA SPP
EP3350337A4 (en) * 2015-09-15 2019-04-03 Advaxis, Inc. METHOD FOR PRODUCING IMMUNOTHERAPEUTIC FORMULATION WITH A RECOMBINANT LISTERIA STRAIN
CA3035591A1 (en) 2016-11-30 2018-06-07 Advaxis, Inc. Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof
AU2018336988B2 (en) 2017-09-19 2023-06-22 Advaxis, Inc. Compositions and methods for lyophilization of bacteria or Listeria strains
CN111349645B (zh) * 2018-12-24 2022-05-17 上海若泰医药科技有限公司 一种提高非整合减毒李斯特菌疫苗安全性的方法
KR102052108B1 (ko) * 2019-08-16 2019-12-04 주식회사 쎌바이오텍 영양요구성 마커를 포함하는 재조합 플라스미드, 이를 포함하는 항암 약물 위장관 전달용 미생물 및 그를 포함하는 항암 약제학적 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) * 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US5204252A (en) 1989-02-08 1993-04-20 Henkel Research Corporation Candida tropicalis transformation system
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US5922583A (en) * 1995-10-17 1999-07-13 Biostar Inc. Methods for production of recombinant plasmids
US6099848A (en) 1997-11-18 2000-08-08 The Trustees Of The University Of Pennsylvania Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use
AU2001255196A1 (en) * 2000-03-29 2001-10-08 The Trustees Of The University Of Pennsylvania Compositions and methods for enhancing immunogenicity of antigens
US6855320B2 (en) 2000-03-29 2005-02-15 The Trustees Of The University Of Pennsylvania Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity
TWI221854B (en) 2000-05-26 2004-10-11 Anawrahta Biotech Co Ltd Lac shuttle vectors, kit for expression of a heterologous gene and DNA vaccine carrier containing the same
JP2002253253A (ja) 2001-03-01 2002-09-10 Toyobo Co Ltd 新規ｄｎａ断片及びグラム陰性細菌用新規ベクター
JP2002253212A (ja) 2001-03-02 2002-09-10 Yamaguchi Technology Licensing Organization Ltd 有用酵母の栄養要求性変異株とその育種方法
ATE273256T1 (de) 2001-09-05 2004-08-15 Ferro Gmbh Strahlenhärtbares edelmetallpräparat, dieses enthaltende abziehbilder und verfahren zum dekorieren
US7425449B2 (en) 2002-04-30 2008-09-16 The Regents Of The University Of California Site specific Listeria integration vectors and methods for using the same
GB0211459D0 (en) 2002-05-18 2002-06-26 Cobra Therapeutics Ltd Plasmid stabilisation in vivo
FI116068B (fi) 2003-09-15 2005-09-15 Fit Biotech Oyj Plc Uusi selektiojärjestelmä, siinä käyttökelpoinen vektori, bakteerisolukantoja sekä menetelmä solujen valikoimiseksi
US7855064B2 (en) * 2004-08-13 2010-12-21 The Trustees Of The University Of Pennsylvania Antibiotic resistance free vaccines and methods for constructing and using same
PT2942391T (pt) 2004-08-13 2018-10-09 Univ Pennsylvania Métodos de produção de vacinas não resistentes aos antibióticos

Similar Documents

Publication Publication Date Title
JP2008509677A5 (https=)
Sewell et al. Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7
WO2019002444A9 (en) NEW T CELL RECEPTORS AND IMMUNOTHERAPY USING THE SAME
DK1759013T3 (da) Identificering af overflade-associerede antigener til tumordiagnose
WO2006071107A8 (en) Mite composition, use thereof, method for rearing a phytoseiid predatory mite, rearing system for rearing said phytoseiid predatory mite and methods for biological pest control on a crop
WO2007002261A3 (en) IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF
JP2009515831A5 (https=)
Kuleš et al. New approaches and omics tools for mining of vaccine candidates against vector-borne diseases
US20090169582A1 (en) Recombinant lactobacillus and use of the same
WO2006138567A3 (en) Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
CN115348870A (zh) 通用型嵌合抗原受体t细胞及其应用
JP2014139185A5 (https=)
EP2283847A3 (en) Disease therapy using dying or dead cells
CN109311955A (zh) 一种新的肿瘤特异性多肽及其应用
CN108823229B (zh) 一种重组Vip3 Aa蛋白的制备方法及其应用
CN104371025B (zh) 一种针对宫颈癌具有免疫原性的蛋白及其应用
Macedo et al. Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles
KR20040104464A (ko) 종양을 치료하기 위해 사용되는 세포 항원을 코딩하는뉴클레오티드 서열의 캐리어로서 기능하는 미생물
WO2005063969A3 (fr) Methodes d'identification et de preparation de lymphocytes t regulateurs/suppresseurs, compositions et utilisations
WO2008127450A3 (en) Linear expression cassette vaccines
CN1708587B (zh) 作为抗恶性疟的潜在疫苗的重组mva株
WO2009008912A3 (en) Mycobacterial mutants inducing il-12
CN100513569C (zh) 重组幽门螺杆菌热休克蛋白60
CN101969991A (zh) 可诱导细胞介导免疫的疟疾疫苗组合物和组分
WO2005100390A3 (en) Bob-1 specific t cells and methods to use